Hideki Nagao

CIK: 0001315306

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MNOV

MEDICINOVA INC

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

MNOV
MEDICINOVA INC
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
44.5K shares-
MNOV
MEDICINOVA INC
Jun 17, 2025
Award(A)
Stock Option (Right to Buy)
Direct
20K shares-
MNOV
MEDICINOVA INC
Feb 12, 2025
Award(A)
Stock Option (Right to Buy)
Direct
24.5K shares-

		Type	Shares	Price		Ownership
Jun 23, 2026	MNOV MEDICINOVA INC	Award(A) Stock Option (Right to Buy)	44,500	-	-	Direct
Jun 17, 2025	MNOV MEDICINOVA INC	Award(A) Stock Option (Right to Buy)	20,000	-	-	Direct
Feb 12, 2025	MNOV MEDICINOVA INC	Award(A) Stock Option (Right to Buy)	24,500	-	-	Direct

1-3 of 3 transactions

About Nagao Hideki

Nagao Hideki (SEC CIK 0001315306) files insider reports with the SEC as Director of MEDICINOVA INC (MNOV).

Signal8 holds 3 ownership filings by Nagao Hideki, all Form 4s, filed between Feb 14, 2025 and Jun 25, 2026. Those filings report 3 transactions, from Feb 12, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nagao Hideki's filings is in LA JOLLA, CA.

Recent filings by Nagao Hideki

Jun 23, 2026: Grant or award of MNOV derivative securities (Form 4, code A).
Jun 17, 2025: Grant or award of MNOV derivative securities (Form 4, code A).
Feb 12, 2025: Grant or award of MNOV derivative securities (Form 4, code A).

Other insiders filing for MEDICINOVA INC (MNOV)

3D Investment Partners Pte. Ltd., Officer
Lemerond Nicole, Director
BEAVER CAROLYN, Director
Matsuda Kazuko, Chief Medical Officer
IWAKI YUICHI, President and CEO

How to read Form 4 transaction codes